Why the study?
Does transcoronary ethanol ablation (TCEA) successfully treat nearly incessant ventricular tachycardia in a patient with prosthetic double valve replacement?
Does transcoronary ethanol ablation (TCEA) successfully treat nearly incessant ventricular tachycardia in a patient with prosthetic double valve replacement?
Transcoronary ethanol ablation is a viable option for treating incessant ventricular tachycardia when left ventricular access is impeded by prosthetic double valve replacement.
Answers are grounded in this paper and cite their sources.
May offer a treatment option for incessant VT with prosthetic valve-impeded LV access; hypothesis-generating and requires validation.
Transcoronary ethanol ablation (TCEA) for ventricular tachycardia (VT) is a treatment option for selected patients when endocardial and epicardial ablation have failed. We present a case of successful TCEA for treatment of nearly incessant VT in a patient in whom access to the left ventricle (LV) was impeded because of prosthetic double valve replacement.
No takes yet. Share an insight, caveat, or question.
Baldinger et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: